In vivo studies showed that ITC-6102RO significantly inhibited tumor growth in B7-H3-overexpressing JIMT-1 xenograft models and in two cases of B7-H3-overexpressing lung cancer PDX models (Figs. 7 and 8). This evidence concerns the gene CD276 and neoplasm.